**Chapter 8**

*Immune Response Activation and Immunomodulation*

[105] Li L, Petrovsky N. Molecular mechanisms for enhanced DNA vaccine immunogenicity. Expert Review of Vaccines. 2016;**15**(3):313-329. DOI: 10.1586/14760584.2016.1124762

[106] Kim TW, Hung CF, Ling M, Juang J, He L, Hardwick JM, et al. Enhancing DNA vaccine potency by coadministration of DNA encoding antiapoptotic proteins. The Journal of Clinical Investigation. 2003. DOI:

[107] Leitner WW, Restifo NP. DNA vaccines and apoptosis: To kill or not to kill? The Journal of Clinical Investigation. 2003. DOI: 10.1172/

[108] Huang B, Mao CP, Peng S, He L, Hung CF, Wu TC. Intradermal administration of DNA vaccines combining a strategy to bypass antigen processing with a strategy to prolong dendritic cell survival enhances DNA vaccine potency. Vaccine. 2007. DOI:

10.1016/j.vaccine.2007.08.036

vol15-issue5-fulltext-2

[109] Iz SG, Çalimlioǧlu B, Gürhan SID. Using Bcl-xL anti-apoptotic protein for altering target cell apoptosis. Electronic Journal of Biotechnology. 2012. DOI: 10.2225/

10.1172/JCI200317293

JCI200319069

**150**
